yield10.png
Yield10 Bioscience to Present at the Benzinga Biotech Small Cap Conference on March 25, 2021
March 18, 2021 08:30 ET | Yield10 Bioscience, Inc.
WOBURN, Mass., March 18, 2021 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq: YTEN), an agricultural bioscience company, today announced that it will be featured as a presenting company at the...
yield10.png
Yield10 Bioscience Announces Fourth Quarter and Full Year 2020 Financial Results
March 16, 2021 16:05 ET | Yield10 Bioscience, Inc.
WOBURN, Mass., March 16, 2021 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN), an agricultural bioscience company, today reported financial results for the three and twelve months ended...
yield10.png
Yield10 Bioscience to Present at Maxim Group’s 2021 Inaugural Emerging Growth Virtual Conference
March 11, 2021 08:30 ET | Yield10 Bioscience, Inc.
WOBURN, Mass., March 11, 2021 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq: YTEN), an agricultural bioscience company, announces that Chief Executive Officer Oliver Peoples, PhD. will...
yield10.png
Yield10 Bioscience to Announce Fourth Quarter and Full Year 2020 Financial Results and Host a Conference Call on Tuesday, March 16, 2021
March 09, 2021 08:30 ET | Yield10 Bioscience, Inc.
WOBURN, Mass., March 09, 2021 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN), an agricultural bioscience company, today announced that the Company will report its fourth quarter and full...
yield10.png
Yield10 Bioscience to Present at Bank of America 2021 Virtual Global Agriculture & Materials Conference on March 4, 2021
March 01, 2021 08:30 ET | Yield10 Bioscience, Inc.
WOBURN, Mass., March 01, 2021 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN), an agricultural bioscience company, today announced it will be featured as a presenting company at the Bank...
yield10.png
Yield10 Bioscience Announces Warrant Exercises for Proceeds of $3.8 million
February 19, 2021 08:30 ET | Yield10 Bioscience, Inc.
WOBURN, Mass., Feb. 19, 2021 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN), an agricultural bioscience company, today announced that it has received proceeds of approximately $3.8...
yield10.png
Yield10 Bioscience Announces Closing of $12.7 Million Public Offering
February 03, 2021 12:15 ET | Yield10 Bioscience, Inc.
WOBURN, Mass., Feb. 03, 2021 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq: YTEN), an agricultural bioscience company, today announced the closing of its previously announced underwritten...
yield10.png
Yield10 Bioscience Announces Pricing of $12.7 Million Public Offering
January 31, 2021 19:30 ET | Yield10 Bioscience, Inc.
WOBURN, Mass., Jan. 31, 2021 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq: YTEN), an agricultural bioscience company, today announced the pricing of its underwritten public offering of...
yield10.png
Yield10 Bioscience Announces Proposed Public Offering of Common Stock
January 29, 2021 16:53 ET | Yield10 Bioscience, Inc.
WOBURN, Mass., Jan. 29, 2021 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq: YTEN), an agricultural bioscience company, today announced it has commenced an underwritten public offering of...
yield10.png
Yield10 Bioscience Announces Achievement of Proof-of-Concept Milestone for Producing PHA Bioplastic in Field Grown Camelina Plants
January 19, 2021 08:30 ET | Yield10 Bioscience, Inc.
WOBURN, Mass., Jan. 19, 2021 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN), an agricultural bioscience company, today announced successful field testing of prototype lines of the...